Last reviewed · How we verify

NCT03328702

CPAP to Improve Swallow Function Post Total Laryngectomy

Completed NA Results posted Last updated 24 December 2024
What this trial tests

NA trial testing Continuous Positive Airway Pressure in Oropharyngeal Dysphagia in 4 participants. Completed in 8 November 2022.

Timeline
27 June 2016
Primary endpoint
8 November 2022
8 November 2022

Quick facts

Lead sponsorUniversity of California, Davis
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposesupportive care
Enrollment4
Start date27 June 2016
Primary completion8 November 2022
Estimated completion8 November 2022
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of California, Davis

Who can join

18 and older, any sex, with Oropharyngeal Dysphagia or Laryngectomy; Status. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Total Pharyngeal Transit Time (With CPAP) Primary · During VFSE (1 day)

This is the time in seconds that it takes for a bolus to move from the oral cavity, through the pharynx, and into the so. It is measured in seconds and is the primary outcome measure.

GroupValue95% CI
Continue Positive Airway Pressure10.18± 8.5

Sponsor's own description

Investigator initiated prospective study to determine whether use of Continuous Positive Airway Pressure (CPAP) can improve the swallow function in patients who underwent total laryngectomy and are experiencing difficulty swallowing

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Continuous Positive Airway Pressure

Trials testing the same drug.

Other recruiting trials for Oropharyngeal Dysphagia

Currently open trials in the same condition.

Other University of California, Davis trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03328702.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing